Concepedia

Author

Katherine McArthur

University of California San Diego

Also Known As

K. McArthur, Katherine A Mcarthur, Katherine A. McArthur, Katherine McArthur

24

Publications

579

Citations

10

H-Index

27

Concepts

All Affiliations

University of California San DiegoTechnical University of MunichUniversity of Maryland, BaltimoreWayne State UniversityThe University of Texas MD Anderson Cancer Center
KM

About

Katherine McArthur is an author at University of California San Diego specializing in biochemistry, medicine, and medicinal chemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biochemistry

4

4

187

2

Medicine

3

3

173

3

Natural Sciences

3

3

172

4

Engineering

2

2

49

5

Biomolecular Engineering

1

1

15

Katherine McArthur

×

10

Publications

560

Citations

10

H-Index

YearCitations

Lynamicins A−E, Chlorinated Bisindole Pyrrole Antibiotics from a Novel Marine Actinomycete

Katherine McArthur, Scott S. Mitchell, Ginger Tsueng,

Journal of Natural Products

2008

147

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105

Alexander Drilon, Siqing Fu, Manish R. Patel,

Cancer Discovery

2018

112

Enantioselective Total Synthesis of (−)-Salinosporamide A (NPI-0052)

Taotao Ling, Venkat R. Macherla, Rama Rao Manam,

Organic Letters

2007

86

Leaving Groups Prolong the Duration of 20S Proteasome Inhibition and Enhance the Potency of Salinosporamides

Rama Rao Manam, Katherine McArthur, Ta‐Hsiang Chao,

Journal of Medicinal Chemistry

2008

53

Effects of Halogens on the Production of Salinosporamides by the Obligate Marine Actinomycete Salinispora tropica

Kin S. Lam, Ginger Tsueng, Katherine McArthur,

The Journal of Antibiotics

2007

34

Snapshots of the Fluorosalinosporamide/20S Complex Offer Mechanistic Insights for Fine Tuning Proteasome Inhibition

M. Groll, Katherine McArthur, Venkat R. Macherla,

Journal of Medicinal Chemistry

2009

33

Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs

Amanda Obaidat, Jeffrey Weiss, Brett Wahlgren,

Journal of Pharmacology and Experimental Therapeutics

2011

32

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet H. Kocoglu,

Blood

2021

25

Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

Bhagirathbhai Dholaria, Mehmet H. Kocoglu, Andrew Kin,

Blood

2023

23

Unique butyric acid incorporation patterns for salinosporamides A and B reveal distinct biosynthetic origins

Ginger Tsueng, Katherine McArthur, Barbara C. M. Potts,

Applied Microbiology and Biotechnology

2007

15

Page 1